You are forgetting about the MDMA & psilocybin treatment the company will offer my friend. I agree this share will probably not hit $1 any time soon, But with the next few quarterlies being released on top of the results of their study/licencing, you can turn a nice profit. I believe this company is on a path of redemption and with the increasing turnover and reduced outlay, I expect to see then cash flow neutral in the near future which is what the company needs so that investors can regain confidence in this company rather than thinking it as just a pump and dump.
You are forgetting about the MDMA & psilocybin treatment the...
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ME1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.430M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $103.7K | 25.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 5192971 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 12120671 | 15 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| ME1 (ASX) Chart |